Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy

Detalles Bibliográficos
Autores principales: Manso, L, Ciruelos, E, Codes, M, De la Haba, J, Galan, A, Baena, J, Jaen, A, Gil, M, Murias, A, Blancas, I, Gonzalez, E, Perez, D, Bayo, JL, Mel, J, Garcia-Martinez, E, Cubedo, R, Salvador, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247052/
http://dx.doi.org/10.1186/bcr3025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247052/
http://dx.doi.org/10.1186/bcr3025

Ejemplares similares